UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The impact of bleeding history, von Willebrand factor and PFA–100® on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM‐1VWD

British journal of haematology, 2010-11, Vol.151 (3), p.245-251

2010

Volltextzugriff (PDF)

Something new about type Normandy von Willebrand disease (type 2N VWD)?

Thrombosis and haemostasis, 2004-07, Vol.92 (1), p.1-2

Mazurier, Claudine

2004

Volltextzugriff (PDF)

A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor

Thrombosis and haemostasis, 2000-01, Vol.83 (1), p.107-113

2000

Volltextzugriff (PDF)

Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide

Thrombosis and haemostasis, 2006-09, Vol.96 (3), p.290-294

2006

Volltextzugriff (PDF)

Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology

Best practice & research. Clinical haematology, 2001-06, Vol.14 (2), p.337-347

2001

Volltextzugriff (PDF)

Mutational analysis of the von Willebrand factor gene in type 1 von Willebrand disease using conformation sensitive gel electrophoresis: a comparison of fluorescent and manual techniques

Haematologica (Roma), 2007-04, Vol.92 (4), p.550-553

2007

Volltextzugriff (PDF)

Molecular genetics of type 2 von Willebrand disease

International journal of hematology, 2002-01, Vol.75 (1), p.9-18

2002

Volltextzugriff (PDF)

Composition, Quality Control, and Labeling of Plasma-Derived Products for the Treatment of von Willebrand disease

Seminars in thrombosis and hemostasis, 2006-07, Vol.32 (5), p.529-536

Mazurier, Claudine

2006

Volltextzugriff (PDF)

Conformational changes in the D' domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment

Blood, 2000-05, Vol.95 (10), p.3139-3145

2000

Volltextzugriff (PDF)

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

Blood, 2013-03, Vol.121 (12), p.2336-2339

2013

Volltextzugriff (PDF)

Impaired dimerization of von Willebrand factor subunit due to mutation A2801D in the CK domain results in a recessive type 2A subtype IID von Willebrand disease

Thrombosis and haemostasis, 2006-05, Vol.95 (5), p.776-781

2006

Volltextzugriff (PDF)

Standardisation of von Willebrand Factor in therapeutic concentrates: calibration of the 1st International Standard for von Willebrand Factor concentrate (00/514)

Thrombosis and haemostasis, 2002-09, Vol.88 (3), p.380-386

2002

Volltextzugriff (PDF)

Composition, quality control, and labeling of plasma-derived products for the treatment of von willebrand disease: Laboratory Issues in the Identification and Diagnosis of von Willebrand Disease: On the 80th Anniversary of Erik von Willebrand's Original Publication

Seminars in thrombosis and hemostasis, 2006, Vol.32 (5), p.529-536

MAZURIER, Claudine

2006

Volltextzugriff (PDF)

Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes

Thrombosis and haemostasis, 1999-07, Vol.82 (1), p.40-45

1999

Volltextzugriff (PDF)

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study

Blood, 2004-03, Vol.103 (6), p.2032-2038

2004

Volltextzugriff (PDF)

Identification of the Regulatory Elements of the Human von Willebrand Factor for Binding to Platelet GPIb

The Journal of biological chemistry, 2002-06, Vol.277 (24), p.22063-22072

2002

Volltextzugriff (PDF)

Identification and Characterization of Novel Variations in Platelet G-Protein Coupled Receptor (GPCR) Genes in Patients Historically Diagnosed with Type 1 von Willebrand Disease

PloS one, 2015-12, Vol.10 (12), p.e0143913-e0143913

2015

Volltextzugriff (PDF)

Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibα in an enzyme‐linked immunosorbent assay‐based method: performances in patients with type 2B von Willebrand disease

British journal of haematology, 2006-06, Vol.133 (6), p.655-663

2006

Volltextzugriff (PDF)

Large experience with a factor VIII binding assay of plasma von Willebrand factor using commercial reagents

British journal of haematology, 2002-06, Vol.117 (3), p.716-718

2002

Volltextzugriff (PDF)

Type 2N von Willebrand disease

Current hematology reports, 2005-09, Vol.4 (5), p.350

2005

Volltextzugriff (PDF)

Lactotransferrin binding to its platelet receptor inhibits platelet aggregation

European Journal of Biochemistry, 1993-05, Vol.213 (3), p.1205-1211

1993

Volltextzugriff (PDF)

Fine epitope mapping of monoclonal antibodies to the NH2‐terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domain

British journal of haematology, 1994-05, Vol.87 (1), p.113-118

1994

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(101)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(73)
Biological And Medical Sciences
(58)
Medical Sciences
(49)
Science & Technology
(48)
Life Sciences & Biomedicine
(47)
Hematology
(44)
Hematologic And Hematopoietic Diseases
(42)
Platelet Diseases And Coagulopathies
(38)
Von Willebrand Diseases - Genetics
(33)
Von Willebrand Factor - Genetics
(31)
Von Willebrand Factor - Metabolism
(26)
Von Willebrand Factor
(25)
Female
(24)
Male
(23)
Von Willebrand Diseases - Blood
(21)
Mutation
(20)
Factor Viii - Metabolism
(17)
Von Willebrand Disease
(17)
Von Willebrand Factor - Chemistry
(17)
Cardiovascular System & Cardiology
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The impact of bleeding history, von Willebrand factor and PFA–100® on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM‐1VWD

Something new about type Normandy von Willebrand disease (type 2N VWD)?

A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor

Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide

Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology

Mutational analysis of the von Willebrand factor gene in type 1 von Willebrand disease using conformation sensitive gel electrophoresis: a comparison of fluorescent and manual techniques

Molecular genetics of type 2 von Willebrand disease

Composition, Quality Control, and Labeling of Plasma-Derived Products for the Treatment of von Willebrand disease

Conformational changes in the D' domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD

Impaired dimerization of von Willebrand factor subunit due to mutation A2801D in the CK domain results in a recessive type 2A subtype IID von Willebrand disease

Standardisation of von Willebrand Factor in therapeutic concentrates: calibration of the 1st International Standard for von Willebrand Factor concentrate (00/514)

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

Composition, quality control, and labeling of plasma-derived products for the treatment of von willebrand disease: Laboratory Issues in the Identification and Diagnosis of von Willebrand Disease: On the 80th Anniversary of Erik von Willebrand's Original Publication

Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study

Identification of the Regulatory Elements of the Human von Willebrand Factor for Binding to Platelet GPIb

Identification and Characterization of Novel Variations in Platelet G-Protein Coupled Receptor (GPCR) Genes in Patients Historically Diagnosed with Type 1 von Willebrand Disease

Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibα in an enzyme‐linked immunosorbent assay‐based method: performances in patients with type 2B von Willebrand disease

Large experience with a factor VIII binding assay of plasma von Willebrand factor using commercial reagents

Type 2N von Willebrand disease

Lactotransferrin binding to its platelet receptor inhibits platelet aggregation

Fine epitope mapping of monoclonal antibodies to the NH2‐terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domain

Suchergebnisse filtern